Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.
2.

Nosocomial transmission of HCV in a cardiology ward during the window phase of infection: an epidemiological and molecular investigation.

Lagging LM, Aneman C, Nenonen N, Brandberg A, Grip L, Norkrans G, Lindh M.

Scand J Infect Dis. 2002;34(8):580-2.

PMID:
12238573
3.

Progression of fibrosis in untreated patients with hepatitis C virus infection.

Lagging LM, Westin J, Svensson E, Aires N, Dhillon AP, Lindh M, Wejstål R, Norkrans G.

Liver. 2002 Apr;22(2):136-44.

PMID:
12028408
4.

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.

Westin J, Lagging LM, Spak F, Aires N, Svensson E, Lindh M, Dhillon AP, Norkrans G, Wejstål R.

J Viral Hepat. 2002 May;9(3):235-41.

PMID:
12010513
5.

Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients.

Lagging LM, Meyer K, Westin J, Wejstål R, Norkrans G, Lindh M, Ray R.

J Infect Dis. 2002 Apr 15;185(8):1165-9. Epub 2002 Apr 1.

PMID:
11930327
6.

Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.

Meyer K, Basu A, Przysiecki CT, Lagging LM, Di Bisceglie AM, Conley AJ, Ray R.

J Virol. 2002 Mar;76(5):2150-8.

7.

Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus.

Ray R, Hoft DF, Meyer K, Brown R, Lagging LM, Belshe RB.

Virus Res. 2001 Jun;75(2):147-54.

PMID:
11325469
8.

Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response.

Westin J, Lindh M, Nenonen N, Lagging LM, Norkrans G, Wejstål R.

Scand J Infect Dis. 2001;33(2):110-5.

PMID:
11233844
9.

Chronic hepatitis C in Sweden: genotype distribution over time in different epidemiological settings.

Westin J, Lindh M, Lagging LM, Norkrans G, Wejstål R.

Scand J Infect Dis. 1999;31(4):355-8.

PMID:
10528872
10.

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection.

Westin J, Lagging LM, Wejstål R, Norkrans G, Dhillon AP.

Liver. 1999 Jun;19(3):183-7.

PMID:
10395036
11.
12.
13.

Immune responses to plasmid DNA encoding the hepatitis C virus core protein.

Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R.

J Virol. 1995 Sep;69(9):5859-63.

14.

Treatment of methicillin-resistant Staphylococcus aureus infection with quinupristin/dalfopristin.

Torralba MD, Frey SE, Lagging LM.

Clin Infect Dis. 1995 Aug;21(2):460-1. No abstract available.

PMID:
8562776
15.

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein.

Ray RB, Lagging LM, Meyer K, Steele R, Ray R.

Virus Res. 1995 Aug;37(3):209-20.

PMID:
8533458
16.

Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Ray R, Khanna A, Lagging LM, Meyer K, Choo QL, Ralston R, Houghton M, Becherer PR.

J Virol. 1994 Jul;68(7):4420-6. Erratum in: J Virol 1994 Sep;68(9):6136.

17.

Delayed treatment of pulmonary blastomycosis causing vertebral osteomyelitis, paraspinal abscess, and spinal cord compression.

Lagging LM, Breland CM, Kennedy DJ, Milligan TW, Sokol-Anderson ML, Westblom TU.

Scand J Infect Dis. 1994;26(1):111-5.

PMID:
8191232
18.

Evaluation of QuickVue, a rapid enzyme immunoassay test for the detection of serum antibodies to Helicobacter pylori.

Westblom TU, Lagging LM, Midkiff BR, Czinn SJ.

Diagn Microbiol Infect Dis. 1993 May-Jun;16(4):317-20.

PMID:
8495587

Supplemental Content

Loading ...
Support Center